Top Suppliers:I want be here

847615-14-9

847615-14-9 structure
847615-14-9 structure

Name tert-butyl 4-(4-bromophenyl)-4-cyanopiperidine-1-carboxylate
Synonyms TERT-BUTYL 4-CYANO-4-(4-BROMOROPHENYL)PIPERIDINE-1-CARBOXYLATE
4-(4-Bromophenyl)-4-cyanopiperidine-1-carboxylic acid tert-butyl ester
1-BOC-4-CYANO-4-(4-BROMOPHENYL)-PIPERIDINE
Density 1.4±0.1 g/cm3
Boiling Point 461.2±45.0 °C at 760 mmHg
Molecular Formula C17H21BrN2O2
Molecular Weight 365.265
Flash Point 232.7±28.7 °C
Exact Mass 364.078644
PSA 53.33000
LogP 3.46
Vapour Pressure 0.0±1.1 mmHg at 25°C
Index of Refraction 1.577
Hazard Codes Xn
Risk Phrases 26-36/37
Safety Phrases 26-36/37
HS Code 2933399090

~%

847615-14-9 structure

847615-14-9

Literature: Mitsubishi Tanabe Pharma Corporation Patent: EP1956009 A1, 2008 ; Location in patent: Page/Page column 99 ;

~%

847615-14-9 structure

847615-14-9

Literature: ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2006/136830 A1, 2006 ; Location in patent: Page/Page column 182-183 ; WO 2006/136830 A1
Precursor  2

DownStream  1

HS Code 2933399090
Summary 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%